← SynDRA

GOLVATINIB

SynDRA canonical compound SYN0037771 — structure-anchored drug synonym record

All known targets

• KDR
• MET

Mechanisms of action (all sources)

• VEGFR inhibitor
• MET INHIBITOR
• Hepatocyte growth factor receptor inhibitor
• KDR INHIBITOR
• Vascular endothelial growth factor receptor 2 inhibitor
• KDR MODULATOR
• MET MODULATOR

Cross-references

• PubChem CID: 16118392
• ChEMBL: CHEMBL3039525
• DrugBank: DB11977
• ChEBI: 177746
• KEGG: D10224
• PDB: GV0
• TTD: D09ETH
• LINCS BRD: BRD-K69001009

Synonyms

• E-7050
• E-7050 (GOLVATINIB)
• E7050
• ER-396901-08
• GOLVATINIB (E7050)
• Golvatinib tartrate
• C-Met and VEGF-2 tyrosine kinase inhibitor (oral, cancer), Eisai
• Golvatinib (E7050)
• E 7050
• UNII-516Z3YP58E
• Golvatinib (USAN)
• Golvatinib [USAN]
• 1-N'-[2-fluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
• 516Z3YP58E
• N-[2-Fluoro-4-[[2-[[[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl]amino]pyridin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
• Golvatinib [USAN:INN]
• N-(2-Fluoro-4-{[2-({[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl}amino)pyridin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
• E7050;Golvatinib
• GOLVATINIB [INN]
• GOLVATINIB [WHO-DD]
• GTPL7956
• SCHEMBL1727298
• CHEMBL3039525
• DTXSID40239155
• EX-A830
• CHEBI:177746
• HMS3651J19
• BCP06122
• BDBM50100615
• MFCD22124462
• NSC800107
• NSC808608
• s2859
• ZINC43195317
• AKOS025404927
• CCG-270294
• CS-0595
• DB11977